Gamgee YC Application
San Francisco
Gamgee went through Y Combinator in the Summer 2026 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.
- YC batch
- Summer 2026
- Industry
- HealthcareDrug Discovery and Delivery
- Location
- San Francisco
- Team size
- 2
- Status
- Active
- Launched
- 2026
Founders
Paul ConynghamFounder/CEO
What Gamgee does
Gamgee began with Rosie, founder Paul Conyngham’s dog. After surgery, chemotherapy and immunotherapy failed, Rosie was given months to live. Paul used AI and genomic analysis to identify targets in her tumour, then worked with scientists at UNSW to produce what is believed to be the first fully computationally designed mRNA cancer vaccine delivered to a dog. Following treatment, several tumours shrank significantly and her quality of life improved Gamgee is building an end to end platform for personalised mRNA cancer vaccines for dogs. We sequence a dog’s tumour and healthy DNA, identify mutations unique to its cancer, and design a vaccine that teaches the immune system what to attack. We manage the entire process- from vet intake and tissue collection through genomic analysis, vaccine production, treatment and response monitoring We are now turning that one off effort into a repeatable clinical system. Gamgee is running clinical trials in Australia, working with vets, oncologists and specialised laboratories, and accepting cases globally. Our goal is to make personalised cancer treatment accessible to every dog that needs it- and use each case to improve the treatment for the next
Gamgee's YC application, reconstructed
Y Combinator application
Gamgee, Summer 2026 batch. The real form questions, answered from public data.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Gamgee
Personalised mRNA cancer vaccines for dogs.
We're building an end-to-end platform for personalised mRNA cancer vaccines for dogs. We start by sequencing a dog's tumour and normal tissue, then use AI to identify and rank tumour-specific mutations. Our platform designs a custom mRNA vaccine targeting these mutations, coordinates production, and works with vets to oversee treatment and monitor outcomes.
San Francisco, CA, USA; Remote. The company would remain based there after YC.
San Francisco connects us to both biotech resources and the YC ecosystem. We operate remotely to collaborate with labs, vets, and trial sites in Australia and globally.
21 more answers in the full application
Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.
Frequently Asked Questions
Is this the real Gamgee YC application?
No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Gamgee's public data (launch notes, founder backgrounds, product description). It shows how a company like Gamgee would present itself to YC, not the text they submitted.
What YC batch was Gamgee in?
Gamgee was part of the Y Combinator Summer 2026 batch.
Who founded Gamgee?
Gamgee was founded by Paul Conyngham.
What does Gamgee do?
Curing cancer. Starting with dogs.
How do I read the full reconstructed application?
Create a free Round Funded account. The full 26-answer version of Gamgee's application, and every other YC batch, is in YC Insights.
More YC startups like Gamgee
